BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28973822)

  • 1. Leucocyte recruitment and molecular fortification of keratinocytes triggered by streptococcal M1 protein.
    Persson ST; Hauri S; Malmström J; Herwald H
    Cell Microbiol; 2018 Jan; 20(1):. PubMed ID: 28973822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation.
    Påhlman LI; Olin AI; Darenberg J; Mörgelin M; Kotb M; Herwald H; Norrby-Teglund A
    Cell Microbiol; 2008 Feb; 10(2):404-14. PubMed ID: 17900297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway.
    Bruun T; Kittang BR; de Hoog BJ; Aardal S; Flaatten HK; Langeland N; Mylvaganam H; Vindenes HA; Skrede S
    Clin Microbiol Infect; 2013 Dec; 19(12):E545-50. PubMed ID: 23795951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vigilant keratinocytes trigger pathogen-associated molecular pattern signaling in response to streptococcal M1 protein.
    Persson ST; Wilk L; Mörgelin M; Herwald H
    Infect Immun; 2015 Dec; 83(12):4673-81. PubMed ID: 26416902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fibrinogen-binding M1 protein reduces pharyngeal cell adherence and colonization phenotypes of M1T1 group A Streptococcus.
    Anderson EL; Cole JN; Olson J; Ryba B; Ghosh P; Nizet V
    J Biol Chem; 2014 Feb; 289(6):3539-46. PubMed ID: 24356958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcus pyogenes Transcriptome Changes in the Inflammatory Environment of Necrotizing Fasciitis.
    Hirose Y; Yamaguchi M; Okuzaki D; Motooka D; Hamamoto H; Hanada T; Sumitomo T; Nakata M; Kawabata S
    Appl Environ Microbiol; 2019 Nov; 85(21):. PubMed ID: 31471300
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection.
    Ashbaugh CD; Warren HB; Carey VJ; Wessels MR
    J Clin Invest; 1998 Aug; 102(3):550-60. PubMed ID: 9691092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive group A streptococcal infections. Serotype newly associated with toxic shock-like syndrome in Trinidad.
    Swanston WH; Woo J; Murphy A; Efstratiou A; Tanna A; Reid HF
    Adv Exp Med Biol; 1997; 418():71-3. PubMed ID: 9331602
    [No Abstract]   [Full Text] [Related]  

  • 9. Group A streptococcal infections in obstetrics and gynecology.
    Rimawi BH; Soper DE; Eschenbach DA
    Clin Obstet Gynecol; 2012 Dec; 55(4):864-74. PubMed ID: 23090455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence and distribution of Streptococcus pyogenes type M in patients treated at the Dr. Fran Mihaljević Infectious Disease Clinic in Zagreb from 1990 to 1996].
    Bejuk D; Begovac J
    Acta Med Croatica; 2002; 56(3):85-91. PubMed ID: 12630338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multifocal inflammatory syndrome after invasive infection due to an M1 strain of Streptococcus pyogenes].
    Filleron A; Marchandin H; Rodière M; Jeziorski E
    Arch Pediatr; 2010 Sep; 17(9):1300-3. PubMed ID: 20709506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for a group A streptococcal vaccine.
    McMillan DJ; Chhatwal GS
    Curr Opin Mol Ther; 2005 Feb; 7(1):11-6. PubMed ID: 15732524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar superantigen gene profiles and superantigen activity in norwegian isolates of invasive and non-invasive group a streptococci.
    Michaelsen TE; Andreasson IK; Langerud BK; Caugant DA
    Scand J Immunol; 2011 Nov; 74(5):423-9. PubMed ID: 21707691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology and virulence characteristics of prevalent group A streptococci recovered from patients in northern India.
    Arya DK; Sharma A; Mehta G; Dua M; Johri AK
    J Infect Dev Ctries; 2014 Mar; 8(3):271-81. PubMed ID: 24619256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quest for GAS vaccine.
    Pandey M; Good MF
    Oncotarget; 2015 Oct; 6(33):34063-4. PubMed ID: 26485764
    [No Abstract]   [Full Text] [Related]  

  • 16. ["Streptococcal toxic shock-like syndrome"].
    Broll R; Eckmann C; Kujath P; Bruch HP
    Chirurg; 1998 Aug; 69(8):806-12. PubMed ID: 9782396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cold Atmospheric Plasma Disarms M1 Protein, an Important Streptococcal Virulence Factor.
    Persson ST; Ekström S; Papareddy P; Herwald H
    J Innate Immun; 2020; 12(4):277-290. PubMed ID: 31563899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment.
    Stevens DL
    Emerg Infect Dis; 1995; 1(3):69-78. PubMed ID: 8903167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response.
    Kahn F; Mörgelin M; Shannon O; Norrby-Teglund A; Herwald H; Olin AI; Björck L
    PLoS Pathog; 2008 Sep; 4(9):e1000149. PubMed ID: 18787689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic dissection of the Streptococcus pyogenes M1 protein: regions involved in fibronectin binding and intracellular invasion.
    Cue D; Lam H; Cleary PP
    Microb Pathog; 2001 Nov; 31(5):231-42. PubMed ID: 11710843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.